Merck & Co., Inc. (NYSE:MRK)

Boeing, Travelers Lead DJIA to New High on Friday

January 12, 2018: Markets opened higher Friday on their way to even higher new highs. Nothing seems to get under the bull market's skin, even a slightly higher-than-expected inflation rate. ...
Read Full Story »

Major Pharma Short Interest Takes a Plunge

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

20 More Biopharma Catalysts Coming in 2018

Over the course of 2017, biopharmaceutical companies more or less kept pace with the markets, ending up with a return just a little higher than the S&P 500. But going in ...
Read Full Story »

General Electric, DowDuPont Lead DJIA Higher Thursday

January 4, 2018: Markets opened higher again Thursday and the DJIA posted its first-ever reading above 25,000. About the only surprising thing was soon the Dow hit that level after ...
Read Full Story »

2018 Bull/Bear Outlook Pfizer and Merck: Where Does Major Health Care Go From Here?

Now that 2017 has come and gone, this raging bull market is now nearing nine years old. It is also the strongest bull market that most investors have seen in ...
Read Full Story »

2018 Bull/Bear Outlook: How All 30 DJIA Stocks Will Take the Market to 26,400 or Higher

It is no secret as 2018 kicks into gear that stocks are in the midst of a raging bull market. In fact, this bull market will turn nine years old ...
Read Full Story »

The Worst 5 DJIA Stocks of 2017

Only five stocks among the 30 that make up the Dow Jones Industrial Average (DJIA) closed out 2017 with lower share prices than they started the year with. That's really ...
Read Full Story »

UnitedHealth, American Express Prop Up DJIA on Thursday

December 28, 2017: Markets opened higher Thursday and the three major indexes once again traded with thin volume in a narrow band not too far from the opening line. Among ...
Read Full Story »

More and More Short Sellers Raising the Stakes in Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Meet the Preliminary Dogs of the Dow for 2018

It is no secret that the bull market's strength heading into 2018 is nearing uncharted territory. Wall Street strategists have recently raised their 2018 stock market expectations after the passage ...
Read Full Story »

20 Fresh Stock Buybacks Could Send $100 Billion Back to Shareholders

Investors love when companies pay solid dividends and when they announce strong stock buyback plans. With the tax reform goal of taking corporate taxes down to 21% from 35%, there ...
Read Full Story »

Caterpillar, UnitedHealth Lead DJIA Slide Thursday

December 14, 2017: Markets opened higher again Thursday but shares trickled lower throughout the day led by a drop of around 1% in the healthcare and materials sectors. Only consumer ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Disney, Apple Pace Dow to Monday Gain

December 11, 2017: Markets opened mixed Monday with the DJIA lagging a bit. By mid-afternoon all three major indexes were trading in the green, even if barely. Tech, telecom, and ...
Read Full Story »

Merrill Lynch Says 5 Dow Jones Laggards Could Be 2018 Winners

With just over three weeks left in 2017, it has been another banner year for stocks investors, with double-digit gains in all three major averages. Barring a big end-of-the-year meltdown, ...
Read Full Story »